Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.10    -0.05 (-4.55%)
Bid:
1.00
Ask:
1.10
Spread: 0.10 (10.00%)
Market Cap: £25.80m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Holding(s) in Company

14 Sep 2007 14:05

Provexis PLC14 September 2007 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached PROVEXIS PLC 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights (X) An acquisition or disposal of financial instruments which may ( ) result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (specify): ( ) 3. Full name of person(s) subject to the notification obligation: Cantor Fitzgerald Europe 4. Full name of shareholder(s) (if different from 3.) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 11/09/07 6. Date on which issuer notified: 13/09/07 7. Threshold(s) that is/are crossed or reached: Below 3% 8. Notified details: A. Voting rights attached to shares Class/type of shares (if possible using the Ordinary (GB00B0923P27)ISIN code) Situation previous to Resulting situation after the triggering transactionthe triggeringtransactionNumber of Number of Number of Number of voting % of voting rightsShares Voting shares rights Rights Direct Direct Indirect Direct Indirect26,991,666 26,991,666 11,991,666 11,991,666 2.99 B. Financial Instruments Resulting situation after the triggering transactionType of Expiration Exercise/ Number of voting % of votingfinancial date Conversion Period/ rights that may rightsinstrument Date be acquired if the instrument is exercised/ converted Total (A+B)Number of voting rights % of voting rights11,991,666 2.99 9. Chain of controlled undertakings through which the voting rights and/ or the financial instruments are effectively held, if applicable: Proxy Voting:10. Name of the proxy holder: N/A 11. Number of voting rights proxy N/A holder will cease to hold: 12. Date on which proxy holder N/A will cease to hold voting rights: 13. Additional information: 14: Contact name: Ross Tanton 15. Contact telephone number: 020 7894 7214 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th May 20267:00 amRNSHolding(s) in Company
16th Apr 202612:37 pmRNSHolding(s) in Company
31st Dec 20258:22 amRNSHalf-year Financial Report
31st Dec 20258:22 amRNSHalf-year Financial Report
21st Nov 20251:38 pmRNSResult of AGM
30th Oct 20257:30 amRNSRestoration - Provexis plc
30th Oct 20257:00 amRNSFinal Results
1st Oct 20257:30 amRNSSuspension - Provexis PLC
30th Sep 20258:40 amRNSDelay in publication of annual accounts
7th Jan 20251:14 pmRNSGrant of Options and Warrants
31st Dec 20241:00 pmRNSTotal Voting Rights
31st Dec 20249:59 amRNSHalf-year Report
18th Dec 20247:00 amRNSPurchase of Fruitflow® II SD & royalty payment
25th Oct 20243:47 pmRNSResult of AGM
30th Sep 20247:00 amRNSFinal Results
30th Apr 20245:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSIssue of Equity - purchase of Fruitflow® II SD
29th Dec 202312:48 pmRNSHalf-year Report
26th Oct 20231:51 pmRNSResult of AGM
29th Sep 20237:00 amRNSFinal Results
30th Aug 20237:04 amRNSBYHEALTH regulatory filing with Chinese SAMR
3rd Apr 20237:00 amRNSCapital structure and funding update
24th Jan 202311:03 amRNSGrant of Share Options
30th Dec 20228:53 amRNSHalf-year Report
27th Oct 20221:12 pmRNSResult of AGM
14th Oct 20227:00 amRNSDirectorate Change
30th Sep 20227:00 amRNSFinal Results
22nd Jun 20227:00 amRNSTwo new agreements with DSM & patent application
31st May 20225:00 pmRNSTotal Voting Rights
17th May 202212:39 pmRNSExercise of Options and Total Voting Rights
31st Dec 20217:00 amRNSHalf-year Report
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20211:30 pmRNSResult of AGM
4th Nov 202111:07 amRNSBy-Health Fruitflow agreement and support in R&D
1st Oct 20216:04 pmRNSGrant of Share Options
30th Sep 20217:00 amRNSFinal Results
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:35 pmRNSPrice Monitoring Extension
24th Aug 20214:35 pmRNSPrice Monitoring Extension
22nd Jul 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20214:35 pmRNSPrice Monitoring Extension
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
5th Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
26th Feb 20215:00 pmRNSTotal Voting Rights
19th Feb 20217:30 amRNSDirector / PDMR notification
19th Feb 20217:00 amRNSPlacing of new ordinary shares to raise £50,000

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.